Aurinia Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	265.81	235.13	175.51	134.03	45.61	50.12	Upgrade
Revenue Growth (YoY)	20.62%	33.97%	30.95%	193.89%	-9.01%	15660.38%	Upgrade
Cost of Revenue	52.73	49.03	63.79	50.65	52.23	50.33	Upgrade
Gross Profit	213.08	186.1	111.72	83.38	-6.63	-0.21	Upgrade
Selling, General & Admin	109.57	172.03	195.04	196.37	173.54	97.27	Upgrade
Other Operating Expenses	16	1.55	2.48	-1.52	0.57	6.81	Upgrade
Operating Expenses	131.97	173.58	197.52	194.85	174.11	104.08	Upgrade
Operating Income	81.1	12.52	-85.79	-111.47	-180.74	-104.29	Upgrade
Interest Expense	-4.43	-4.84	-2.78	-	-	-	Upgrade
Interest & Investment Income	14.06	16.97	17	5.12	0.53	1.52	Upgrade
Currency Exchange Gain (Loss)	5.9	5.9	-5.9	-	-	-	Upgrade
EBT Excluding Unusual Items	96.64	30.55	-77.47	-106.35	-180.21	-102.77	Upgrade
Merger & Restructuring Charges	-17	-23.11	-	-	-	-	Upgrade
Pretax Income	79.64	7.45	-77.47	-106.35	-180.21	-102.77	Upgrade
Income Tax Expense	1.8	1.7	0.55	1.83	0.76	-0.09	Upgrade
Net Income	77.84	5.75	-78.02	-108.18	-180.97	-102.68	Upgrade
Net Income to Common	77.84	5.75	-78.02	-108.18	-180.97	-102.68	Upgrade
Shares Outstanding (Basic)	137	143	143	142	129	118	Upgrade
Shares Outstanding (Diluted)	142	146	143	142	129	118	Upgrade
Shares Change (YoY)	-1.24%	2.07%	0.93%	9.70%	9.20%	27.36%	Upgrade
EPS (Basic)	0.57	0.04	-0.54	-0.76	-1.40	-0.87	Upgrade
EPS (Diluted)	0.55	0.04	-0.54	-0.76	-1.40	-0.87	Upgrade
Free Cash Flow	119.64	44.11	-34.18	-79.82	-158	-75.53	Upgrade
Free Cash Flow Per Share	0.84	0.30	-0.24	-0.56	-1.22	-0.64	Upgrade
Gross Margin	80.16%	79.15%	63.66%	62.21%	-14.53%	-0.42%	Upgrade
Operating Margin	30.51%	5.32%	-48.88%	-83.17%	-396.31%	-208.09%	Upgrade
Profit Margin	29.28%	2.45%	-44.45%	-80.71%	-396.81%	-204.88%	Upgrade
Free Cash Flow Margin	45.01%	18.76%	-19.47%	-59.55%	-346.44%	-150.70%	Upgrade
EBITDA	100.55	31.96	-74.14	-108.76	-177.97	-102.92	Upgrade
EBITDA Margin	37.83%	13.59%	-42.24%	-81.15%	-	-205.35%	Upgrade
D&A For EBITDA	19.45	19.45	11.65	2.71	2.76	1.37	Upgrade
EBIT	81.1	12.52	-85.79	-111.47	-180.74	-104.29	Upgrade
EBIT Margin	30.51%	5.32%	-48.88%	-83.17%	-	-208.09%	Upgrade
Effective Tax Rate	2.26%	22.77%	-	-	-	-	Upgrade
Revenue as Reported	265.81	235.13	175.51	134.03	45.61	50.12	Upgrade

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q